The session led by Will Hind, Founder and CEO, Alpharmaxim, will cover the theory of behavioural science, provide examples from other industries, describe a research project utilising behavioural science in Parkinson’s disease, explain how behavioural science can be incorporated into planning and how it will increase the effectiveness and efficiency of your communications.

This workshop offers a valuable insight into the structure and function of the pharmaceutical industry.

In a sector which revolves around patients, we need to ensure that they are at the heart of our narrative.